Because
Your Next
Step Matters


Once-Daily ALUNBRIG® (brigatinib)

What Is ALUNBRIG®?

ALUNBRIG is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC):

  • that has a certain type of abnormal
    anaplastic lymphoma kinase (ALK) gene, and
  • that has spread to other parts of your body, and
  • who have taken the medicine crizotinib, but their NSCLC
    worsened or they cannot tolerate taking crizotinib

It is not known if ALUNBRIG is safe and effective in children.

There is an ongoing study to learn how ALUNBRIG works over a longer period of time.

Learn About ALUNBRIG

How ALUNBRIG Works >

Taking Your Medication

How to Take ALUNBRIG >

Access and Support Program

ALUNBRIG Resources >

Stay Connected. Register for Updates >

ALUNBRIG(TM) BRIGATINIB 39 mg TABLETS

This site is intended for residents
of the US and US territories only.

You are now leaving ALUNBRIG.com, the official site for ALUNBRIG® (brigatinib) and entering one that is not owned or controlled by Takeda Oncology.

Takeda Oncology makes no representation as to the accuracy of the information contained on sites we do not own or control. Takeda Oncology does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Cancel Continue >
Close

You are now leaving ALUNBRIG.com, the official site for ALUNBRIG® (brigatinib) and entering one that is not owned or controlled by Takeda Oncology.

This link will take you to the corporate ARIAD Pharmaceuticals, Inc. website.

Cancel Continue >
Close

You are now leaving ALUNBRIG.com, the official site for ALUNBRIG® (brigatinib).

This link will take you to another Takeda Oncology website.

Cancel Continue >
Close

The site you are about to enter is intended for US healthcare professionals only.

Please confirm that you are a US healthcare professional.

Yes, I confirm that I am a US healthcare professional Cancel
Close